RASSF1 and breast carcinoma: Lidocaine, known as an amide-type local anesthetic, has been indicated to promote DNA demethylation 8, 37 and increase the cytotoxicity of cisplatin in breast cancer cells via upregulation of RASSF1A demethylation 8.